AAAAAA

   
Results: 1-25 | 26-28
Results: 1-25/28

Authors: Damberg, M Garpenstrand, H Hallman, J Oreland, L
Citation: M. Damberg et al., Genetic mechanisms of behavior - Don't forget about the transcription factors, MOL PSYCHI, 6(5), 2001, pp. 503-510

Authors: Gronvall-Nordquist, JLE Backlund, LB Garpenstrand, L Ekblom, J Landin, B Yu, PH Oreland, L Rosenqvist, U
Citation: Jle. Gronvall-nordquist et al., Follow-up of plasma semicarbazide-sensitive amine oxidase activity and retinopathy in Type 2 diabetes mellitus, J DIABET C, 15(5), 2001, pp. 250-256

Authors: Garpenstrand, H Annas, P Ekblom, J Oreland, L Fredrikson, M
Citation: H. Garpenstrand et al., Human fear conditioning is related to dopaminergic and serotonergic biological markers, BEHAV NEURO, 115(2), 2001, pp. 358-364

Authors: Damberg, M Eller, M Tonissaar, M Oreland, L Harro, J
Citation: M. Damberg et al., Levels of transcription factors AP-2 alpha and AP-2 beta in the brainstem are correlated to monoamine turnover in the rat forebrain, NEUROSCI L, 313(1-2), 2001, pp. 102-104

Authors: Harro, M Eensoo, D Kiive, E Merenakk, L Alep, J Oreland, L Harro, J
Citation: M. Harro et al., Platelet monoamine oxidase in healthy 9-and 15-years old children: The effect of gender, smoking and puberty, PROG NEUR-P, 25(8), 2001, pp. 1497-1511

Authors: Obata, T Yamanaka, Y Kinemuchi, H Oreland, L
Citation: T. Obata et al., Release of dopamine by perfusion with 1-methyl-4-phenylpyridinium ion (MPP+) into the striatum is associated with hydroxyl free radical generation, BRAIN RES, 906(1-2), 2001, pp. 170-175

Authors: Sakurai, E Sakurai, E Tanaka, Y Watanabe, T Jossan, SS Oreland, L
Citation: E. Sakurai et al., Effects of histamine H3-receptor ligands on brain monoamine oxidase in various mammalian species, BRAIN RES, 906(1-2), 2001, pp. 180-183

Authors: Harro, J Tonissaar, M Eller, M Kask, A Oreland, L
Citation: J. Harro et al., Chronic variable stress and partial 5-HT denervation by parachloroamphetamine treatment in the rat: effects on behavior and monoamine neurochemistry, BRAIN RES, 899(1-2), 2001, pp. 227-239

Authors: Kinemuchi, H Kobayashi, N Takahashi, K Takayanagi, K Arai, Y Tadano, T Kisara, K Oreland, L
Citation: H. Kinemuchi et al., Inhibition of tissue-bound semicarbazide-sensitive amine oxidase by two haloamines, 2-bromoethylamine and 3-bromopropylamine, ARCH BIOCH, 385(1), 2001, pp. 154-161

Authors: Damberg, M Garpenstrand, H Alfredsson, J Ekblom, J Forslund, K Rylander, G Oreland, L
Citation: M. Damberg et al., A polymorphic region in the human transcription factor AP-2 beta gene is associated with specific personality traits, MOL PSYCHI, 5(2), 2000, pp. 220-224

Authors: Harro, J Merikula, A Lepiku, M Modiri, AR Rinken, A Oreland, L
Citation: J. Harro et al., Lesioning of Locus coeruleus projections by DSP-4 neurotoxin treatment: Effect on amphetamine-induced hyperlocomotion and dopamine D-2 receptor binding in rats, PHARM TOX, 86(5), 2000, pp. 197-202

Authors: Prince, JA Harro, J Blennow, K Gottfries, CG Oreland, L
Citation: Ja. Prince et al., Putamen mitochondrial energy metabolism is highly correlated to emotional and intellectual impairment in schizophrenics, NEUROPSYCH, 22(3), 2000, pp. 284-292

Authors: Damberg, M Garpenstrand, H Berggard, C Asberg, M Hallman, J Oreland, L
Citation: M. Damberg et al., The genotype of human transcription factor AP-2 beta is associated with platelet monoamine oxidase B activity, NEUROSCI L, 291(3), 2000, pp. 204-206

Authors: Garpenstrand, H Ekblom, J Forslund, K Rylander, G Oreland, L
Citation: H. Garpenstrand et al., Platelet monoamine oxidase activity is related to MAOB intron 13 genotype, J NEURAL TR, 107(5), 2000, pp. 523-530

Authors: Kask, A Eller, M Oreland, L Harro, J
Citation: A. Kask et al., Neuropeptide Y attenuates the effect of locus coeruleus denervation by DSP-4 treatment on social behaviour in the rat, NEUROPEPTID, 34(1), 2000, pp. 58-61

Authors: Damberg, M Ekblom, J Oreland, L
Citation: M. Damberg et al., Chronic pharmacological treatment with certain antidepressants alters the expression and DNA-binding activity of transcription factor AP-2, LIFE SCI, 68(6), 2000, pp. 669-678

Authors: Yassin, MS Ekblom, J Xilinas, M Gottfries, CG Oreland, L
Citation: Ms. Yassin et al., Changes in uptake of vitamin B-12 and trace metals in brains of mice treated with clioquinol, J NEUR SCI, 173(1), 2000, pp. 40-44

Authors: Jonsson, EG Norton, N Gustavsson, JF Oreland, L Owen, MJ Sedvall, GC
Citation: Eg. Jonsson et al., A promoter polymorphism in the monoamine oxidase A gene and its relationships to monoamine metabolite concentrations in CSF of healthy volunteers, J PSYCH RES, 34(3), 2000, pp. 239-244

Authors: Kinemuchi, H Jinbo, M Tabata, A Toyoshima, Y Arai, Y Tadano, T Kisara, K Oreland, L
Citation: H. Kinemuchi et al., 2-Bromoethylamine, a suicide inhibitor of tissue-bound semicarbazide-sensitive amine oxidase, JPN J PHARM, 83(2), 2000, pp. 164-166

Authors: Harro, J Haidkind, R Harro, M Modiri, AR Gillberg, PG Pahkla, R Matto, V Oreland, L
Citation: J. Harro et al., Chronic mild unpredictable stress after noradrenergic denervation: attenuation of behavioural and biochemical effects of DSP-4 treatment, EUR NEUROPS, 10(1), 1999, pp. 5-16

Authors: Prince, JA Blennow, K Gottfries, CG Karlsson, I Oreland, L
Citation: Ja. Prince et al., Mitochondrial function is differentially altered in the basal ganglia of chronic schizophrenics, NEUROPSYCH, 21(3), 1999, pp. 372-379

Authors: Garpenstrand, H Ekblom, J Backlund, LB Oreland, L Rosenqvist, U
Citation: H. Garpenstrand et al., Elevated plasma semicarbazide-sensitive amine oxidase (SSAO) activity in Type 2 diabetes mellitus complicated by retinopathy, DIABET MED, 16(6), 1999, pp. 514-521

Authors: Harro, J Pahkla, R Modiri, AR Harro, M Kask, A Oreland, L
Citation: J. Harro et al., Dose-dependent effects of noradrenergic denervation by DSP-4 treatment on forced swimming and beta-adrenoceptor binding in the rat, J NEURAL TR, 106(7-8), 1999, pp. 619-629

Authors: Ekblom, J Gronvall, J Lennernast, B Nilsson, S Garpenstrand, H Oreland, L
Citation: J. Ekblom et al., Elevated activity of semicarbazide-sensitive amine oxidase in blood from patients with skeletal metastases of prostate cancer, CLIN SCI, 97(1), 1999, pp. 111-115

Authors: Garpenstrand, H Ekblom, J von Arbin, M Oreland, L Murray, V
Citation: H. Garpenstrand et al., Plasma semicarbazide-sensitive amine oxidase in stroke, EUR NEUROL, 41(1), 1999, pp. 20-23
Risultati: 1-25 | 26-28